Injectable Micro-Hydrogel for DNA Delivery: A Promising Therapeutic Platform

Area of Science:

• Biomaterials Science
• Immunology
• Cell Therapy

Background:

• Dendritic cells (DCs) are crucial for adaptive immunity and hold potential for cell-based therapies.
• Developing injectable, biocompatible scaffolds is essential for in vivo immune modulation.
• Alginate hydrogels offer a programmable and easily prepared platform for advanced medical applications.

Purpose of the Study:

• To synthesize injectable alginate scaffolds loaded with DCs and CpG DNA microparticles (MPs).
• To evaluate the viability and proliferation of encapsulated DCs.
• To assess the potential for immune stimulation via DC phagocytosis of CpG MPs.

Main Methods:

• Alginate balls were synthesized and loaded with DCs or CpG DNA MPs.
• DC proliferation and viability were monitored in alginate scaffolds for up to 7 days.
• DC phagocytosis of CpG MPs was confirmed in a 2D model, followed by synthesis of alginate balls with CpG-MP-uptaken DCs.
• Injectability was modulated by adjusting syringe needle gauges.

Main Results:

• Encapsulated DCs demonstrated proliferation within alginate balls for 7 days.
• CpG MPs were uniformly dispersed, facilitating DC uptake.
• Alginate balls containing DCs that had phagocytosed CpG MPs were successfully synthesized.
• The injectability of the alginate balls was tunable via needle gauge.

Conclusions:

• Injectable alginate scaffolds support DC proliferation and function.
• This system enables controlled delivery of DCs and immune stimuli for potential therapeutic applications.
• The developed strategy offers a promising, comfortable approach for immune modulation in medical treatments.